Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocotrienol and Bevacizumab in Advanced Ovarian Cancer
NCT02399592Phase 2Completed
- Sponsor
- Vejle Hospital
- Start
- Mar 2015
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in ovarian cancer, sponsored by Vejle Hospital. Primary endpoint: Fraction of patients without progression at 6 months. Started Mar 2015; status: completed.
02
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT02399592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02399592.